Chapter 2 Epidemiology of the Antiphospholipid Syndrome [Internet] In: Handbook of Systemic Autoimmune Diseases, p.13, 2009. ,
Epidemiology of the Antiphospholipid Antibody Syndrome, Journal of Autoimmunity, vol.15, issue.2, pp.145-51, 2000. ,
DOI : 10.1006/jaut.2000.0409
High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population, Clin Exp Immunol, vol.69, pp.557-65, 1987. ,
Significance of persistent antiphospholipid antibodies in the elderly, J Rheumatol, vol.33, pp.1559-62, 2006. ,
The geoepidemiology of the antiphospholipid antibody syndrome, Autoimmunity Reviews, vol.9, issue.5, pp.299-304, 2010. ,
DOI : 10.1016/j.autrev.2009.11.013
Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients, Arthritis & Rheumatism, vol.15, issue.suppl 7, pp.1019-1046, 2002. ,
DOI : 10.1002/art.10187
Long-Term Follow-Up in 128 Patients With Primary Antiphospholipid Syndrome, Medicine, vol.84, issue.4, pp.225-255, 2005. ,
DOI : 10.1097/01.md.0000172074.53583.ea
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients, Annals of the Rheumatic Diseases, vol.82, issue.(Suppl 7), pp.1011-1019, 2015. ,
DOI : 10.1136/annrheumdis-2013-204838
Editorial, Lupus, vol.25, issue.6, pp.489-90, 1997. ,
DOI : 10.1177/096120339700600601
Markers of cardiovascular risk in patients with antiphospholipid syndrome: A meta-analysis of literature studies, Annals of Medicine, vol.192, issue.8, pp.693-702, 2014. ,
DOI : 10.1016/j.autrev.2011.01.004
Anti-Cardiolipin Antibodies and Risk of Myocardial Infarction in a Prospective Cohort of Middle-Aged Men, Circulation, vol.91, issue.1, pp.23-30, 1995. ,
DOI : 10.1161/01.CIR.91.1.23
Anticardiolipin Antibodies and Recurrent Coronary Events : A Prospective Study of 1150 Patients, Circulation, vol.102, issue.11, pp.1258-63, 2000. ,
DOI : 10.1161/01.CIR.102.11.1258
Update on the Catastrophic Antiphospholipid Syndrome and the ???CAPS Registry???, Seminars in Thrombosis and Hemostasis, vol.38, issue.04, pp.333-341, 2012. ,
DOI : 10.1055/s-0032-1304718
14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome, 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome, pp.699-707, 2014. ,
DOI : 10.1016/j.autrev.2014.03.002
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines, Lupus, vol.42, issue.7, pp.530-534, 2003. ,
DOI : 10.1191/0961203303lu394oa
Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients, Arthritis & Rheumatism, vol.11, issue.8, pp.2568-76, 2006. ,
DOI : 10.1002/art.22018
High thrombosis rate after fetal loss in antiphospholipid syndrome: Effective prophylaxis with aspirin, Arthritis & Rheumatism, vol.160, issue.6, pp.1466-1473, 2001. ,
DOI : 10.1002/1529-0131(200106)44:6<1466::AID-ART242>3.0.CO;2-C
Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case???control study, Annals of the Rheumatic Diseases, vol.71, issue.1, pp.61-67, 2012. ,
DOI : 10.1136/ard.2011.153817
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases, Autoimmunity Reviews, vol.14, issue.5, pp.387-95, 2015. ,
DOI : 10.1016/j.autrev.2014.12.010
The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome, Rheumatology, vol.45, issue.3, pp.332-340, 2006. ,
DOI : 10.1093/rheumatology/kei159
Predictive value of sequential models of uterine artery Doppler in pregnancies at high risk for pre-eclampsia, Ultrasound in Obstetrics & Gynecology, vol.110, issue.Suppl, pp.68-74, 2012. ,
DOI : 10.1002/uog.10147
High Prevalence of Significant Heart Valve Lesions in Patients with the 'Primary' Antiphospholipid Syndrome, Lupus, vol.1, issue.1, pp.43-50, 1991. ,
DOI : 10.1177/096120339100100108
Neurological manifestations of antiphospholipid antibody syndrome, Lupus, vol.5, issue.2_suppl, pp.67-74, 1998. ,
DOI : 10.1177/096120339800700216
Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome, British Journal of Haematology, vol.98, issue.4, pp.873-882, 1997. ,
DOI : 10.1046/j.1365-2141.1997.3063123.x
A Hemorrhagic Disorder Caused by Circulating Anticoagulant in Patients with Disseminated Lupus Erythematosous, J Lab Clin Invest, vol.31, pp.621-623, 1952. ,
Acquired inhibitors of blood coagulation, Prog Hemost Thromb, vol.1, pp.75-95, 1972. ,
Thrombosis in systemic lupus erythematosus despite circulating anticoagulants, J Lab Clin Med, vol.62, pp.416-446, 1963. ,
The ???Primary??? Antiphospholipid Syndrome, Medicine, vol.68, issue.6, pp.366-74, 1989. ,
DOI : 10.1097/00005792-198911000-00004
Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder., Annals of the Rheumatic Diseases, vol.48, issue.5, pp.362-369, 1989. ,
DOI : 10.1136/ard.48.5.362
ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS, The Lancet, vol.322, issue.8361, pp.1211-1215, 1983. ,
DOI : 10.1016/S0140-6736(83)91267-9
Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH, Thromb Haemost, vol.74, pp.1185-90, 1995. ,
Update of the guidelines for lupus anticoagulant detection, Journal of Thrombosis and Haemostasis, vol.27, issue.10, pp.1737-1777, 2009. ,
DOI : 10.1111/j.1538-7836.2009.03555.x
BIOLOGICALLY FALSE POSITIVE SEROLOGIC TESTS FOR SYPHILIS, Journal of the American Medical Association, vol.150, issue.5, pp.467-73, 1952. ,
DOI : 10.1001/jama.1952.03680050033010
Biologically false positive reactions to serological tests for syphilis, Bull World Health Organ, vol.14, p.235, 1956. ,
Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results, Clin Exp Immunol, vol.62, pp.738-783, 1985. ,
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)., Proceedings of the National Academy of Sciences, vol.87, issue.11, pp.4120-4124, 1990. ,
DOI : 10.1073/pnas.87.11.4120
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor, The Lancet, vol.335, issue.8705, pp.1544-1551, 1990. ,
DOI : 10.1016/0140-6736(90)91374-J
Anti-??2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome, Blood, vol.102, issue.8, pp.2717-2740, 2003. ,
DOI : 10.1182/blood-2002-11-3334
The Second International Anti-Cardiolipin Standardization Workshop/The Kingston Anti-Phospholipid Antibody Study (KAPS) Group, American Journal of Clinical Pathology, vol.94, issue.4, pp.476-84, 1990. ,
DOI : 10.1093/ajcp/94.4.476
-glycoprotein??I: proof of concept, Journal of Thrombosis and Haemostasis, vol.87, issue.5, pp.833-875, 2009. ,
DOI : 10.1111/j.1538-7836.2009.03316.x
URL : https://hal.archives-ouvertes.fr/hal-01273468
A non-complement-fixing antibody to ??2 glycoprotein I as a novel therapy for antiphospholipid syndrome, Blood, vol.123, issue.22, pp.3478-87, 2014. ,
DOI : 10.1182/blood-2013-11-537704
Antiphospholipid syndrome: antibodies to Domain 1 of ??2-glycoprotein 1 correctly classify patients at risk, Journal of Thrombosis and Haemostasis, vol.13, issue.5, pp.782-789, 2015. ,
DOI : 10.1111/jth.12865
Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis, Lupus, vol.333, issue.1, pp.15-22, 1998. ,
DOI : 10.1191/096120398678919688
Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study, Lupus, vol.35, issue.14, pp.1468-76, 2014. ,
DOI : 10.1001/archinte.164.1.77
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study, Blood, vol.118, issue.17, pp.4714-4722, 2011. ,
DOI : 10.1182/blood-2011-03-340232
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature, Blood, vol.101, issue.5, pp.1827-1859, 2003. ,
DOI : 10.1182/blood-2002-02-0441
Determinants of Risk for Venous and Arterial Thrombosis in Primary Antiphospholipid Syndrome and in Antiphospholipid Syndrome with Systemic Lupus Erythematosus, The Journal of Rheumatology, vol.36, issue.6, pp.1195-1204, 2009. ,
DOI : 10.3899/jrheum.081194
Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: A systematic review and meta-analysis, Autoimmunity Reviews, vol.13, issue.6, pp.595-608, 2014. ,
DOI : 10.1016/j.autrev.2013.11.004
Antibody profiles for the diagnosis of antiphospholipid syndrome, Thromb Haemost, vol.93, pp.1147-52, 2005. ,
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome, Journal of Thrombosis and Haemostasis, vol.106, issue.2, pp.237-279, 2010. ,
DOI : 10.1111/j.1538-7836.2009.03674.x
Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies, BMJ, vol.330, issue.7491, pp.565-565, 2005. ,
DOI : 10.1136/bmj.38380.674340.E0
Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis, J Rheumatol, vol.33, pp.2214-2235, 2006. ,
Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset, BMC Pregnancy and Childbirth, vol.100, issue.1, p.11, 2009. ,
DOI : 10.1016/S0029-7844(02)02165-8
Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy, Thrombosis Research, vol.123, issue.3, pp.482-489, 2009. ,
DOI : 10.1016/j.thromres.2008.03.012
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study, Rheumatology, vol.50, issue.9, pp.1684-1693, 2011. ,
DOI : 10.1093/rheumatology/ker139
Clinical and serological features of the antiphospholipid syndrome (APS), Br J Rheumatol, vol.26, p.19, 1987. ,
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop, Arthritis & Rheumatism, vol.7, issue.7, pp.1309-1320, 1999. ,
DOI : 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), Journal of Thrombosis and Haemostasis, vol.75, issue.2, pp.295-306, 2006. ,
DOI : 10.1080/00313020310001643615
Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: An international and collaborative meta-analysis, Autoimmunity Reviews, vol.13, issue.3, pp.281-91, 2014. ,
DOI : 10.1016/j.autrev.2013.10.014
Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies, Autoimmunity Reviews, vol.14, issue.3, pp.192-200, 2015. ,
DOI : 10.1016/j.autrev.2014.10.019
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies, Lupus, vol.7, issue.2, pp.206-224, 2011. ,
DOI : 10.1016/S0140-6736(10)60709-X
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome, New England Journal of Medicine, vol.332, issue.15, pp.993-1000, 1995. ,
DOI : 10.1056/NEJM199504133321504
Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients, Annals of Internal Medicine, vol.117, issue.4, pp.303-311, 1992. ,
DOI : 10.7326/0003-4819-117-4-303
Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment., Annals of the Rheumatic Diseases, vol.52, issue.9, pp.689-92, 1993. ,
DOI : 10.1136/ard.52.9.689
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)1, Journal of Thrombosis and Haemostasis, vol.68, issue.5, pp.848-53, 2005. ,
DOI : 10.1001/jama.291.5.576
A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome, New England Journal of Medicine, vol.349, issue.12, pp.1133-1141, 2003. ,
DOI : 10.1056/NEJMoa035241
Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals, J Rheumatol, vol.31, pp.1560-1567, 2004. ,
Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression, Rheumatology, vol.49, issue.2, pp.281-289, 2010. ,
DOI : 10.1093/rheumatology/kep373
Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy, Journal of Thrombosis and Haemostasis, vol.115, issue.10, pp.2208-2221, 2010. ,
DOI : 10.1111/j.1538-7836.2010.04015.x
Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant, Cochrane Database Syst Rev, vol.99, issue.1, p.2859, 2005. ,
DOI : 10.1002/14651858.CD002859.pub2
Antiphospholipid antibodies associated with recurrent pregnancy loss: Prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin, Fertility and Sterility, vol.83, issue.3, pp.684-90, 2005. ,
DOI : 10.1016/j.fertnstert.2004.11.002
Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome, International Journal of Gynecology & Obstetrics, vol.8, issue.3, pp.211-216, 2011. ,
DOI : 10.1016/j.ijgo.2010.09.010
Grossesse et syndrome des antiphospholipides, La Revue de M??decine Interne, vol.33, issue.4, pp.209-225, 2012. ,
DOI : 10.1016/j.revmed.2012.01.003
Characterization of IgG monoclonal anti-cardiolipin/anti-beta2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies, British Journal of Haematology, vol.117, issue.1, pp.102-111, 1999. ,
DOI : 10.1021/bi960657q
The clonal analysis of anticardiolipin antibodies in a single patient with primary antiphospholipid syndrome reveals an extreme antibody heterogeneity, Blood, vol.97, issue.12, pp.3820-3828, 2001. ,
DOI : 10.1182/blood.V97.12.3820
International consensus guidelines on anticardiolipin and anti-??2-glycoprotein I testing: Report from the 13th International Congress on Antiphospholipid Antibodies, Report from the 13th International Congress on Antiphospholipid Antibodies, pp.1-10, 2012. ,
DOI : 10.1002/art.33349
Standards and reference materials for the anticardiolipin and anti-??2glycoprotein I assays: A report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies, Clinica Chimica Acta, vol.413, issue.1-2, pp.358-60, 2012. ,
DOI : 10.1016/j.cca.2011.09.048
Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification, Journal of Thrombosis and Haemostasis, vol.6, issue.10, pp.1693-1699, 2008. ,
DOI : 10.1111/j.1538-7836.2008.03121.x
ISTH/SSC lupus anticoagulant testing guidelines: how far have these been adopted by laboratories?, Journal of Thrombosis and Haemostasis, vol.134, issue.10, pp.2117-2126, 2011. ,
DOI : 10.1111/j.1538-7836.2011.04448.x
Cooperation experience in a multicentre study to define the upper limits in a normal population for the diagnostic assessment of the functional lupus anticoagulant assays Available from, International Congress on Antiphospholipid Antibodies. Part Two: Poster Presentations, pp.582-633, 2002. ,
Evaluation of different immunoassays for the detection of antiphospholipid antibodies: Report of a wet workshop during the 13th International Congress on Antiphospholipid Antibodies, Report of a wet workshop during the 13th International Congress on Antiphospholipid Antibodies, pp.99-105, 2014. ,
DOI : 10.1016/j.cca.2013.11.009
Autoimmune diseases induced by TNF-targeted therapies, Best Practice & Research Clinical Rheumatology, vol.22, issue.5, pp.847-61, 2008. ,
DOI : 10.1016/j.berh.2008.09.008
Antiphospholipid antibodies, antiphospholipid syndrome and infections, Autoimmunity Reviews, vol.7, issue.4, pp.272-279, 2008. ,
DOI : 10.1016/j.autrev.2007.10.001
Antiphospholipid antibodies and malignancies, Autoimmunity Reviews, vol.9, issue.4, pp.200-202, 2010. ,
DOI : 10.1016/j.autrev.2009.04.001
Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome, International Journal of Medical Sciences, vol.7, pp.15-23, 2009. ,
DOI : 10.7150/ijms.7.15
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke, JAMA, vol.291, pp.576-84, 2004. ,
Confirmation of antiphospholipid antibody positivity: a year???s results in a cohort of 113 patients, Reumatismo, vol.62, issue.1, pp.51-60, 2010. ,
DOI : 10.4081/reumatismo.2010.51
Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile, Journal of Thrombosis and Haemostasis, vol.38, issue.8, pp.1527-1558, 2013. ,
DOI : 10.1111/jth.12264
Clinical and laboratory characteristics of children positive for antiphospholipid antibodies, Blood Transfus Trasfus Sangue, vol.10, pp.296-301, 2012. ,
Antiphospholipid Syndrome in the Elderly: Caution, Circulation, vol.97, issue.22, pp.2195-2201, 1998. ,
DOI : 10.1161/01.CIR.97.22.2195
Retirada de la anticoagulaci??n en el s??ndrome antifosfol??pido primario cuando se negativizan los anticuerpos anticardiolipina, Revista Cl??nica Espa??ola, vol.208, issue.3, pp.135-142, 2008. ,
DOI : 10.1157/13115821
Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative, Immunologic Research, vol.11, issue.9751, pp.358-61, 2013. ,
DOI : 10.1007/s12026-013-8407-x